sq-11725 has been researched along with Kidney Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avdeef, A; Tam, KY | 1 |
| Epstein, M; Oster, JR | 1 |
| Achber, C; Gupta, RN; Haynes, RB; Logan, AG; Macdonald, LA; Pickersgill, R | 1 |
| Katus, H; Mall, G; Mehls, O; Rambausek, M; Ritz, E | 1 |
1 review(s) available for sq-11725 and Kidney Diseases
| Article | Year |
|---|---|
Beta-blockers and the kidney.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Cardiac Output; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Nadolol; Physical Exertion; Propanolamines; Propranolol; Renal Circulation; Renin; Sympathomimetics; Vascular Resistance | 1982 |
3 other study(ies) available for sq-11725 and Kidney Diseases
| Article | Year |
|---|---|
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Liquid-chromatographic determination of nadolol in plasma.
Topics: Antihypertensive Agents; Chromatography, Liquid; Humans; Kidney Diseases; Nadolol; Propanolamines; Spectrometry, Fluorescence; Time Factors | 1983 |
Myocardial hypertrophy in rats with renal insufficiency.
Topics: Adenosine Triphosphatases; Animals; Blood Pressure; Blood Transfusion; Calcium; Cardiomegaly; Hydralazine; Isoenzymes; Kidney Diseases; Male; Metoprolol; Microscopy, Electron; Myocardium; Myosins; Nadolol; Nephrectomy; Organ Size; Parathyroid Glands; Prazosin; Propanolamines; Rats; Rats, Inbred Strains; Trifluoperazine | 1985 |